Elevance Health (ELV) Revenue (2009 - 2026)

Elevance Health (ELV) has reported Revenue for 18 consecutive years, with $50.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 1.4% year-over-year to $50.5 billion in Q2 2026; TTM through Jun 2026 was $201.1 billion, a 6.29% increase from a year earlier, with the FY2025 full-year figure at $199.1 billion, up 12.49% from the prior year.
• Revenue was $50.5 billion for Q2 2026 at Elevance Health, up from $50.2 billion in the prior quarter.
• Over five years, Revenue peaked at $50.7 billion in Q3 2025 and troughed at $38.1 billion in Q1 2022.
• A 5-year average of $44.7 billion and a median of $43.8 billion in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue increased 17.63% in 2022 and grew 0.49% in 2024, its largest moves.
• Over 5 years, Revenue stood at $39.9 billion in 2022, then increased by 6.81% to $42.6 billion in 2023, then grew by 6.55% to $45.4 billion in 2024, then advanced by 9.47% to $49.7 billion in 2025, then grew by 1.46% to $50.5 billion in 2026.
• The last three Revenue figures came in at $50.5 billion (Q2 2026), $50.2 billion (Q1 2026), and $49.7 billion (Q4 2025), per Business Quant data.